Skip to main content
Erschienen in: Reactions Weekly 1/2023

01.09.2023 | Case report

Tozinameran

Guillain-Barre-syndrome: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2023

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Saso N, et al. Post-COVID-19 vaccination Guillain-Barre syndrome with sensory ataxia, gaze-evoked nystagmus, mental-status change and positive pathological reflex. Clinical and Experimental Neuroimmunology 14 : 142-145, No. 3, Apr 2023. Available from: URL: http://doi.org/10.1111/cen3.12754 [abstract] Saso N, et al. Post-COVID-19 vaccination Guillain-Barre syndrome with sensory ataxia, gaze-evoked nystagmus, mental-status change and positive pathological reflex. Clinical and Experimental Neuroimmunology 14 : 142-145, No. 3, Apr 2023. Available from: URL: http://​doi.​org/​10.​1111/​cen3.​12754 [abstract]
Metadaten
Titel
Tozinameran
Guillain-Barre-syndrome: case report
Publikationsdatum
01.09.2023
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2023
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-023-45997-6

Weitere Artikel der Ausgabe 1/2023

Reactions Weekly 1/2023 Zur Ausgabe

Case report

Valproate

Case report

Carbimazole

Case report

Multiple drugs